nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Risedronate—PTGS2—thyroid cancer	0.00754	0.529	CrCbGaD
Pamidronate—Clodronate—PTGS2—thyroid cancer	0.00672	0.471	CrCbGaD
Pamidronate—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00212	0.00215	CcSEcCtD
Pamidronate—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00211	0.00214	CcSEcCtD
Pamidronate—Myalgia—Sorafenib—thyroid cancer	0.00211	0.00214	CcSEcCtD
Pamidronate—Arthralgia—Sorafenib—thyroid cancer	0.00211	0.00214	CcSEcCtD
Pamidronate—Herpes simplex—Doxorubicin—thyroid cancer	0.0021	0.00213	CcSEcCtD
Pamidronate—Hyperkalaemia—Epirubicin—thyroid cancer	0.00205	0.00208	CcSEcCtD
Pamidronate—Diarrhoea—Vandetanib—thyroid cancer	0.00205	0.00208	CcSEcCtD
Pamidronate—Influenza like illness—Epirubicin—thyroid cancer	0.00203	0.00206	CcSEcCtD
Pamidronate—Bone pain—Doxorubicin—thyroid cancer	0.00202	0.00205	CcSEcCtD
Pamidronate—Anaphylactic shock—Sorafenib—thyroid cancer	0.00202	0.00205	CcSEcCtD
Pamidronate—Infection—Sorafenib—thyroid cancer	0.00201	0.00203	CcSEcCtD
Pamidronate—Candida infection—Epirubicin—thyroid cancer	0.002	0.00203	CcSEcCtD
Pamidronate—Inflammation—Doxorubicin—thyroid cancer	0.00199	0.00202	CcSEcCtD
Pamidronate—Shock—Sorafenib—thyroid cancer	0.00199	0.00201	CcSEcCtD
Pamidronate—Nervous system disorder—Sorafenib—thyroid cancer	0.00198	0.00201	CcSEcCtD
Pamidronate—Dizziness—Vandetanib—thyroid cancer	0.00198	0.00201	CcSEcCtD
Pamidronate—Thrombocytopenia—Sorafenib—thyroid cancer	0.00198	0.00201	CcSEcCtD
Pamidronate—Blood urea increased—Epirubicin—thyroid cancer	0.00197	0.002	CcSEcCtD
Pamidronate—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00196	0.00199	CcSEcCtD
Pamidronate—Anorexia—Sorafenib—thyroid cancer	0.00192	0.00195	CcSEcCtD
Pamidronate—Vomiting—Vandetanib—thyroid cancer	0.0019	0.00193	CcSEcCtD
Pamidronate—Hyperkalaemia—Doxorubicin—thyroid cancer	0.0019	0.00193	CcSEcCtD
Pamidronate—Rash—Vandetanib—thyroid cancer	0.00189	0.00191	CcSEcCtD
Pamidronate—Dermatitis—Vandetanib—thyroid cancer	0.00189	0.00191	CcSEcCtD
Pamidronate—Influenza like illness—Doxorubicin—thyroid cancer	0.00188	0.00191	CcSEcCtD
Pamidronate—Headache—Vandetanib—thyroid cancer	0.00187	0.0019	CcSEcCtD
Pamidronate—Pulmonary oedema—Epirubicin—thyroid cancer	0.00186	0.00189	CcSEcCtD
Pamidronate—Candida infection—Doxorubicin—thyroid cancer	0.00185	0.00187	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00184	0.00187	CcSEcCtD
Pamidronate—Blood urea increased—Doxorubicin—thyroid cancer	0.00183	0.00185	CcSEcCtD
Pamidronate—Dyspnoea—Sorafenib—thyroid cancer	0.0018	0.00183	CcSEcCtD
Pamidronate—Nausea—Vandetanib—thyroid cancer	0.00178	0.0018	CcSEcCtD
Pamidronate—Dyspepsia—Sorafenib—thyroid cancer	0.00178	0.0018	CcSEcCtD
Pamidronate—Phlebitis—Epirubicin—thyroid cancer	0.00176	0.00179	CcSEcCtD
Pamidronate—Decreased appetite—Sorafenib—thyroid cancer	0.00175	0.00178	CcSEcCtD
Pamidronate—Thrombophlebitis—Epirubicin—thyroid cancer	0.00175	0.00178	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00174	0.00177	CcSEcCtD
Pamidronate—Fatigue—Sorafenib—thyroid cancer	0.00174	0.00177	CcSEcCtD
Pamidronate—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00174	0.00176	CcSEcCtD
Pamidronate—Constipation—Sorafenib—thyroid cancer	0.00173	0.00175	CcSEcCtD
Pamidronate—Pain—Sorafenib—thyroid cancer	0.00173	0.00175	CcSEcCtD
Pamidronate—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00172	0.00175	CcSEcCtD
Pamidronate—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00167	0.0017	CcSEcCtD
Pamidronate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00165	0.00167	CcSEcCtD
Pamidronate—Renal failure acute—Epirubicin—thyroid cancer	0.00164	0.00167	CcSEcCtD
Pamidronate—Phlebitis—Doxorubicin—thyroid cancer	0.00163	0.00165	CcSEcCtD
Pamidronate—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00162	0.00165	CcSEcCtD
Pamidronate—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00161	0.00163	CcSEcCtD
Pamidronate—Abdominal pain—Sorafenib—thyroid cancer	0.0016	0.00162	CcSEcCtD
Pamidronate—Body temperature increased—Sorafenib—thyroid cancer	0.0016	0.00162	CcSEcCtD
Pamidronate—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00157	0.00159	CcSEcCtD
Pamidronate—Cardiac failure—Epirubicin—thyroid cancer	0.00156	0.00158	CcSEcCtD
Pamidronate—Lethargy—Epirubicin—thyroid cancer	0.00155	0.00157	CcSEcCtD
Pamidronate—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00155	0.00157	CcSEcCtD
Pamidronate—Renal failure acute—Doxorubicin—thyroid cancer	0.00152	0.00154	CcSEcCtD
Pamidronate—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00152	0.00154	CcSEcCtD
Pamidronate—Osteoarthritis—Epirubicin—thyroid cancer	0.00152	0.00154	CcSEcCtD
Pamidronate—Hypersensitivity—Sorafenib—thyroid cancer	0.00149	0.00151	CcSEcCtD
Pamidronate—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00145	0.00147	CcSEcCtD
Pamidronate—Asthenia—Sorafenib—thyroid cancer	0.00145	0.00147	CcSEcCtD
Pamidronate—Cardiac failure—Doxorubicin—thyroid cancer	0.00144	0.00146	CcSEcCtD
Pamidronate—Lethargy—Doxorubicin—thyroid cancer	0.00143	0.00145	CcSEcCtD
Pamidronate—Pruritus—Sorafenib—thyroid cancer	0.00143	0.00145	CcSEcCtD
Pamidronate—Blood creatinine increased—Epirubicin—thyroid cancer	0.00142	0.00144	CcSEcCtD
Pamidronate—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.0014	0.00142	CcSEcCtD
Pamidronate—Osteoarthritis—Doxorubicin—thyroid cancer	0.0014	0.00142	CcSEcCtD
Pamidronate—Liver function test abnormal—Epirubicin—thyroid cancer	0.0014	0.00142	CcSEcCtD
Pamidronate—Hypokalaemia—Epirubicin—thyroid cancer	0.00138	0.0014	CcSEcCtD
Pamidronate—Diarrhoea—Sorafenib—thyroid cancer	0.00138	0.0014	CcSEcCtD
Pamidronate—Nasopharyngitis—Epirubicin—thyroid cancer	0.00136	0.00138	CcSEcCtD
Pamidronate—Gastritis—Epirubicin—thyroid cancer	0.00134	0.00136	CcSEcCtD
Pamidronate—Dizziness—Sorafenib—thyroid cancer	0.00133	0.00135	CcSEcCtD
Pamidronate—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00132	0.00133	CcSEcCtD
Pamidronate—Influenza—Epirubicin—thyroid cancer	0.00131	0.00133	CcSEcCtD
Pamidronate—Liver function test abnormal—Doxorubicin—thyroid cancer	0.0013	0.00132	CcSEcCtD
Pamidronate—Vomiting—Sorafenib—thyroid cancer	0.00128	0.0013	CcSEcCtD
Pamidronate—Hypokalaemia—Doxorubicin—thyroid cancer	0.00128	0.0013	CcSEcCtD
Pamidronate—Rash—Sorafenib—thyroid cancer	0.00127	0.00129	CcSEcCtD
Pamidronate—Dermatitis—Sorafenib—thyroid cancer	0.00127	0.00129	CcSEcCtD
Pamidronate—Headache—Sorafenib—thyroid cancer	0.00126	0.00128	CcSEcCtD
Pamidronate—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00126	0.00127	CcSEcCtD
Pamidronate—Gastritis—Doxorubicin—thyroid cancer	0.00124	0.00126	CcSEcCtD
Pamidronate—Neutropenia—Epirubicin—thyroid cancer	0.00123	0.00124	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00122	0.00124	CcSEcCtD
Pamidronate—Influenza—Doxorubicin—thyroid cancer	0.00121	0.00123	CcSEcCtD
Pamidronate—Nausea—Sorafenib—thyroid cancer	0.0012	0.00122	CcSEcCtD
Pamidronate—Pneumonia—Epirubicin—thyroid cancer	0.00118	0.00119	CcSEcCtD
Pamidronate—Infestation—Epirubicin—thyroid cancer	0.00117	0.00119	CcSEcCtD
Pamidronate—Infestation NOS—Epirubicin—thyroid cancer	0.00117	0.00119	CcSEcCtD
Pamidronate—Renal failure—Epirubicin—thyroid cancer	0.00115	0.00117	CcSEcCtD
Pamidronate—Stomatitis—Epirubicin—thyroid cancer	0.00114	0.00116	CcSEcCtD
Pamidronate—Urinary tract infection—Epirubicin—thyroid cancer	0.00114	0.00115	CcSEcCtD
Pamidronate—Conjunctivitis—Epirubicin—thyroid cancer	0.00114	0.00115	CcSEcCtD
Pamidronate—Neutropenia—Doxorubicin—thyroid cancer	0.00114	0.00115	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00113	0.00114	CcSEcCtD
Pamidronate—Haematuria—Epirubicin—thyroid cancer	0.00112	0.00113	CcSEcCtD
Pamidronate—Sinusitis—Epirubicin—thyroid cancer	0.0011	0.00111	CcSEcCtD
Pamidronate—Agranulocytosis—Epirubicin—thyroid cancer	0.00109	0.00111	CcSEcCtD
Pamidronate—Pneumonia—Doxorubicin—thyroid cancer	0.00109	0.0011	CcSEcCtD
Pamidronate—Infestation NOS—Doxorubicin—thyroid cancer	0.00108	0.0011	CcSEcCtD
Pamidronate—Infestation—Doxorubicin—thyroid cancer	0.00108	0.0011	CcSEcCtD
Pamidronate—Renal failure—Doxorubicin—thyroid cancer	0.00106	0.00108	CcSEcCtD
Pamidronate—Haemoglobin—Epirubicin—thyroid cancer	0.00106	0.00107	CcSEcCtD
Pamidronate—Stomatitis—Doxorubicin—thyroid cancer	0.00106	0.00107	CcSEcCtD
Pamidronate—Rhinitis—Epirubicin—thyroid cancer	0.00105	0.00107	CcSEcCtD
Pamidronate—Urinary tract infection—Doxorubicin—thyroid cancer	0.00105	0.00107	CcSEcCtD
Pamidronate—Conjunctivitis—Doxorubicin—thyroid cancer	0.00105	0.00107	CcSEcCtD
Pamidronate—Haemorrhage—Epirubicin—thyroid cancer	0.00105	0.00107	CcSEcCtD
Pamidronate—Urinary tract disorder—Epirubicin—thyroid cancer	0.00104	0.00105	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—thyroid cancer	0.00103	0.00105	CcSEcCtD
Pamidronate—Connective tissue disorder—Epirubicin—thyroid cancer	0.00103	0.00105	CcSEcCtD
Pamidronate—Urethral disorder—Epirubicin—thyroid cancer	0.00103	0.00104	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—thyroid cancer	0.00102	0.00103	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—thyroid cancer	0.00101	0.00102	CcSEcCtD
Pamidronate—Eye disorder—Epirubicin—thyroid cancer	0.000981	0.000996	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—thyroid cancer	0.000977	0.000991	CcSEcCtD
Pamidronate—Cardiac disorder—Epirubicin—thyroid cancer	0.000975	0.000989	CcSEcCtD
Pamidronate—Flushing—Epirubicin—thyroid cancer	0.000975	0.000989	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—thyroid cancer	0.000974	0.000988	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—thyroid cancer	0.000972	0.000986	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00096	0.000973	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000955	0.000969	CcSEcCtD
Pamidronate—Angiopathy—Epirubicin—thyroid cancer	0.000953	0.000967	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—thyroid cancer	0.000952	0.000966	CcSEcCtD
Pamidronate—Immune system disorder—Epirubicin—thyroid cancer	0.000949	0.000962	CcSEcCtD
Pamidronate—Mediastinal disorder—Epirubicin—thyroid cancer	0.000946	0.00096	CcSEcCtD
Pamidronate—Chills—Epirubicin—thyroid cancer	0.000942	0.000956	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—thyroid cancer	0.000928	0.000941	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—thyroid cancer	0.000914	0.000927	CcSEcCtD
Pamidronate—Erythema—Epirubicin—thyroid cancer	0.000914	0.000927	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—thyroid cancer	0.000908	0.000921	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—thyroid cancer	0.000902	0.000915	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—thyroid cancer	0.000902	0.000915	CcSEcCtD
Pamidronate—Tension—Epirubicin—thyroid cancer	0.000897	0.00091	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—thyroid cancer	0.000895	0.000908	CcSEcCtD
Pamidronate—Nervousness—Epirubicin—thyroid cancer	0.000888	0.000901	CcSEcCtD
Pamidronate—Back pain—Epirubicin—thyroid cancer	0.000884	0.000897	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—thyroid cancer	0.000882	0.000894	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—thyroid cancer	0.000879	0.000892	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—thyroid cancer	0.000878	0.00089	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000876	0.000888	CcSEcCtD
Pamidronate—Chills—Doxorubicin—thyroid cancer	0.000872	0.000884	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—thyroid cancer	0.000859	0.000871	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—thyroid cancer	0.000848	0.00086	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—thyroid cancer	0.000846	0.000858	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—thyroid cancer	0.000846	0.000858	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—thyroid cancer	0.000845	0.000857	CcSEcCtD
Pamidronate—Agitation—Epirubicin—thyroid cancer	0.00084	0.000852	CcSEcCtD
Pamidronate—Tension—Doxorubicin—thyroid cancer	0.00083	0.000842	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—thyroid cancer	0.000828	0.00084	CcSEcCtD
Pamidronate—Malaise—Epirubicin—thyroid cancer	0.000824	0.000836	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—thyroid cancer	0.000822	0.000833	CcSEcCtD
Pamidronate—Syncope—Epirubicin—thyroid cancer	0.00082	0.000832	CcSEcCtD
Pamidronate—Leukopenia—Epirubicin—thyroid cancer	0.000818	0.00083	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—thyroid cancer	0.000818	0.00083	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—thyroid cancer	0.000813	0.000825	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—thyroid cancer	0.000803	0.000815	CcSEcCtD
Pamidronate—Cough—Epirubicin—thyroid cancer	0.000798	0.000809	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—thyroid cancer	0.000792	0.000803	CcSEcCtD
Pamidronate—Hypertension—Epirubicin—thyroid cancer	0.000789	0.000801	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000785	0.000796	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—thyroid cancer	0.000782	0.000793	CcSEcCtD
Pamidronate—Arthralgia—Epirubicin—thyroid cancer	0.000778	0.00079	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—thyroid cancer	0.000778	0.00079	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—thyroid cancer	0.000777	0.000789	CcSEcCtD
Pamidronate—Anxiety—Epirubicin—thyroid cancer	0.000776	0.000787	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—thyroid cancer	0.000769	0.00078	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—thyroid cancer	0.000763	0.000774	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—thyroid cancer	0.000759	0.000769	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—thyroid cancer	0.000757	0.000768	CcSEcCtD
Pamidronate—Confusional state—Epirubicin—thyroid cancer	0.000752	0.000763	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—thyroid cancer	0.000746	0.000757	CcSEcCtD
Pamidronate—Oedema—Epirubicin—thyroid cancer	0.000746	0.000757	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—thyroid cancer	0.000743	0.000754	CcSEcCtD
Pamidronate—Infection—Epirubicin—thyroid cancer	0.000741	0.000752	CcSEcCtD
Pamidronate—Cough—Doxorubicin—thyroid cancer	0.000738	0.000749	CcSEcCtD
Pamidronate—Shock—Epirubicin—thyroid cancer	0.000734	0.000745	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—thyroid cancer	0.000733	0.000743	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—thyroid cancer	0.000732	0.000742	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—thyroid cancer	0.00073	0.000741	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—thyroid cancer	0.00073	0.000741	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—thyroid cancer	0.000728	0.000739	CcSEcCtD
Pamidronate—Hyperhidrosis—Epirubicin—thyroid cancer	0.000721	0.000732	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—thyroid cancer	0.00072	0.000731	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—thyroid cancer	0.00072	0.000731	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—thyroid cancer	0.000718	0.000728	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—thyroid cancer	0.000711	0.000722	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—thyroid cancer	0.000711	0.000721	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—thyroid cancer	0.000697	0.000707	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—thyroid cancer	0.000696	0.000706	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00069	0.0007	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—thyroid cancer	0.00069	0.0007	CcSEcCtD
Pamidronate—Infection—Doxorubicin—thyroid cancer	0.000686	0.000696	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00068	0.00069	CcSEcCtD
Pamidronate—Shock—Doxorubicin—thyroid cancer	0.000679	0.000689	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—thyroid cancer	0.000677	0.000687	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000676	0.000686	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—thyroid cancer	0.000675	0.000685	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—thyroid cancer	0.000674	0.000683	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—thyroid cancer	0.00067	0.00068	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000667	0.000677	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—thyroid cancer	0.000665	0.000675	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—thyroid cancer	0.000663	0.000673	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—thyroid cancer	0.000658	0.000668	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—thyroid cancer	0.000657	0.000666	CcSEcCtD
Pamidronate—Decreased appetite—Epirubicin—thyroid cancer	0.000649	0.000658	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—thyroid cancer	0.000645	0.000654	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000644	0.000653	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—thyroid cancer	0.000643	0.000653	CcSEcCtD
Pamidronate—Constipation—Epirubicin—thyroid cancer	0.000638	0.000647	CcSEcCtD
Pamidronate—Pain—Epirubicin—thyroid cancer	0.000638	0.000647	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000629	0.000638	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—thyroid cancer	0.000624	0.000633	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—thyroid cancer	0.00062	0.000629	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—thyroid cancer	0.000615	0.000624	CcSEcCtD
Pamidronate—Feeling abnormal—Epirubicin—thyroid cancer	0.000615	0.000624	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—thyroid cancer	0.000614	0.000623	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00061	0.000619	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—thyroid cancer	0.000608	0.000616	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—thyroid cancer	0.0006	0.000609	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000596	0.000605	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—thyroid cancer	0.000595	0.000604	CcSEcCtD
Pamidronate—Pain—Doxorubicin—thyroid cancer	0.00059	0.000599	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—thyroid cancer	0.00059	0.000599	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—thyroid cancer	0.00059	0.000598	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—thyroid cancer	0.00059	0.000598	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—thyroid cancer	0.000569	0.000577	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000564	0.000573	CcSEcCtD
Pamidronate—Hypersensitivity—Epirubicin—thyroid cancer	0.00055	0.000558	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—thyroid cancer	0.000546	0.000554	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—thyroid cancer	0.000546	0.000554	CcSEcCtD
Pamidronate—Asthenia—Epirubicin—thyroid cancer	0.000535	0.000543	CcSEcCtD
Pamidronate—Pruritus—Epirubicin—thyroid cancer	0.000528	0.000535	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—thyroid cancer	0.00051	0.000518	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—thyroid cancer	0.000509	0.000516	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—thyroid cancer	0.000495	0.000502	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—thyroid cancer	0.000493	0.0005	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—thyroid cancer	0.000488	0.000495	CcSEcCtD
Pamidronate—Vomiting—Epirubicin—thyroid cancer	0.000474	0.000481	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—thyroid cancer	0.000472	0.000479	CcSEcCtD
Pamidronate—Rash—Epirubicin—thyroid cancer	0.00047	0.000477	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—thyroid cancer	0.00047	0.000477	CcSEcCtD
Pamidronate—Headache—Epirubicin—thyroid cancer	0.000467	0.000474	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—thyroid cancer	0.000456	0.000463	CcSEcCtD
Pamidronate—Nausea—Epirubicin—thyroid cancer	0.000443	0.00045	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—thyroid cancer	0.000439	0.000445	CcSEcCtD
Pamidronate—Rash—Doxorubicin—thyroid cancer	0.000435	0.000442	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—thyroid cancer	0.000435	0.000441	CcSEcCtD
Pamidronate—Headache—Doxorubicin—thyroid cancer	0.000432	0.000439	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—thyroid cancer	0.00041	0.000416	CcSEcCtD
